We provide comprehensive support for the custom synthesis of Active Pharmaceutical Ingredients (API)and other specialized molecules, offering consultation and hands-on execution of experimental studies, process development, optimization, and scale-up. With capabilities ranging from milligram-scale explorations to production of hundreds of grams, the lab primarily serves chemical and pharmaceutical companies seeking reliable, high-quality synthetic solutions.
Scope of Synthesis Work
API (Active Pharmaceutical Ingredients)
Non-commercial small molecules
Peptides / PNAs (Peptide Nucleic Acids)
Carbohydrates
Established in 2005, the group collaborates with numerous partners on R&D initiatives in organic synthesis and analytical research. The team comprises scientists with diverse, interdisciplinary expertise—encompassing medicinal chemistry, process development, and advanced analytical methods—ensuring robust support across multiple areas of industrial and research chemistry.
Leveraging profound knowledge in organic and medicinal chemistry, the team designs and synthesizes high-quality APIs aligned with the rigorous demands of pharmaceutical development. Scalable synthetic routes are devised to ensure reproducibility and regulatory compliance, while advanced techniques help optimize yield, purity, and cost-effectiveness. This integrated approach streamlines the shift from initial discovery to large-scale production, accelerating time-to-market without compromising quality.
For research groups in academia and industry, the lab offers custom synthesis of specialized, non-commercial entities, including heterocyclic compounds, nucleic acid derivatives, and small-molecule probes. Decades of experience in tackling challenging synthetic targets enable the development of bespoke solutions. By engaging closely with collaborators, the laboratory delivers high-purity compounds ideal for biological assays, screening programs, and preclinical research.
Peptide and Peptide Nucleic Acid (PNAs) synthesis constitutes a critical component of drug discovery, diagnostics, and molecular biology. The facility offers tailored sequences, site-specific modifications, and custom conjugations to meet exact research or therapeutic objectives. Expertise in high-affinity ligand design, bioactive peptide formulation, and nucleic acid analog development ensures enhanced stability and target specificity—key advantages in translational and clinical studies.
In addition to more common organic targets, the lab provides custom carbohydrate synthesis for applications spanning glycobiology, immunology, and vaccine development. Complex sugar moieties, oligosaccharides, and specialized conjugates can be crafted with precision, supporting a range of functional and structural investigations
For informations, enquiries and pricing please write to: filippo.doria@unipv.it